For a cancer patient who has exhausted all lines of traditional treatment and conventional trials, Compassionate Use is frequently their last resort. Compassionate Use are “trials” in which the FDA and pharmaceutical companies work together to bring a specific treatment to a patient—or a group of patients—which otherwise would not be available. The process of acquiring the medication for a Compassionate Use trial can be very tedious and is typically estimated at nearly 120 hours per Compassionate Use request.